IOL Chemicals And Pharmaceuticals Ltd (IOLCP) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524164 | NSE: IOLCP | Pharmaceuticals & Drugs | Small Cap

IOL Chem & Pharma Share Price

84.53 -2.29 -2.64%
as on 05-Dec'25 16:59

IOL Chemicals And Pharmaceuticals Ltd (IOLCP) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524164 | NSE: IOLCP | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on IOL Chem & Pharma

Based on:

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

IOL Chemicals And Pharmaceuticals stock performance -

Key Ratios
mw4me loader
P/E Ratio (CD):
21.42
Market Cap:
2,481.2 Cr.
52-wk low:
57.5
52-wk high:
126.6

Is IOL Chemicals And Pharmaceuticals Ltd an attractive stock to invest in?

1. Is IOL Chemicals And Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that IOL Chemicals And Pharmaceuticals Ltd is a below average quality company.

2. Is IOL Chemicals And Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of IOL Chemicals And Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is IOL Chemicals And Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of IOL Chemicals And Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of IOL Chem & Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
IOL Chemicals And Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 0%0%0%0%0%0%16.3%13.6%12.2%8.9%-
Value Creation
Index
NANANANANANA0.20.0-0.1-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0000002,1842,2172,1332,0792,170
Sales YoY Gr.-NANANANANANA1.5%-3.8%-2.5%-
Adj EPS 0000005.54.64.33.34
YoY Gr.-NANANANANANA-16.4%-7%-23.9%-
BVPS (₹) 00000047.451.454.957.559.7
Adj Net
Profit
00000016113512595.4116
Cash Flow from Ops. 00000093.1122290179-
Debt/CF from Ops. 0000000.50.70.10.7-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA-1.6%-2.5%
Adj EPS NANA-16%-23.9%
BVPSNANA6.6%4.7%
Share Price 17.2% -11.6% 7.4% 8.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
00000011.69.385.86.7
Op. Profit
Mgn %
00000011.910.210.89.710.5
Net Profit
Mgn %
0000007.46.15.94.65.3
Debt to
Equity
00000000.100.10
Working Cap
Days
000000019819418294
Cash Conv.
Cycle
000000075756846

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 6.70%

Sales growth has been subdued in last 3 years -1.63%

Net Profit has been subdued in last 3 years -16.03%

Sales growth is not so good in last 4 quarters at 5.77%

Latest Financials - IOL Chemicals And Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 4 4
TTM Sales (₹ Cr.) 2,170 2,170
BVPS (₹.) 59.7 59.7
Reserves (₹ Cr.) 1,692 1,693
P/BV 1.42 1.42
PE 21.37 21.42
From the Market
52 Week Low / High (₹) 57.51 / 126.60
All Time Low / High (₹) 0.07 / 179.68
Market Cap (₹ Cr.) 2,481
Equity (₹ Cr.) 58.7
Face Value (₹) 2
Industry PE 40.6

Management X-Ray of IOL Chem & Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of IOL Chem & Pharma - Consolidated Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of IOL Chem & Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales2,1842,2172,1332,079
Operating Expenses 1,9261,9911,9021,877
Manufacturing Costs115175197162
Material Costs1,5711,5471,3971,392
Employee Cost 141168201217
Other Costs 99101108106
Operating Profit 258226231202
Operating Profit Margin (%) 11.8%10.2%10.8%9.7%
Other Income 32263022
Interest 8161615
Depreciation 43466372
Exceptional Items -14000
Profit Before Tax 225189182138
Tax 57504737
Profit After Tax 168139134101
PAT Margin (%) 7.7%6.3%6.3%4.9%
Adjusted EPS (₹)5.74.74.63.4
Dividend Payout Ratio (%)14%17%22%23%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 1,3921,5081,6121,688
Share Capital 59595959
Reserves 1,3341,4491,5531,629
Minority Interest0000
Debt438033117
Long Term Debt0000
Short Term Debt438033117
Trade Payables409314469428
Others Liabilities 180167168178
Total Liabilities 2,0242,0682,2822,411

Fixed Assets

Gross Block7629951,2361,544
Accumulated Depreciation201243303374
Net Fixed Assets 5617529331,171
CWIP 1059010122
Investments 2202021
Inventories410326425361
Trade Receivables470505471514
Cash Equivalents 14022143208
Others Assets 336354188115
Total Assets 2,0242,0682,2822,411

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 93122290179
PBT 225189182138
Adjustment 33446080
Changes in Working Capital -102-6490-21
Tax Paid -63-47-42-18
Cash Flow From Investing Activity -121-120-191-154
Capex -151-210-272-213
Net Investments 22806846
Others 891412
Cash Flow From Financing Activity -2-4-9346
Net Proceeds from Shares 0000
Net Proceeds from Borrowing 0000
Interest Paid -8-16-16-15
Dividend Paid -35-24-29-23
Others 4236-4784
Net Cash Flow -29-2670

Finance Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)12.049.68.626.13
ROCE (%)16.2513.5712.248.86
Asset Turnover Ratio1.081.080.980.89
PAT to CFO Conversion(x)0.550.882.161.77
Working Capital Days
Receivable Days79808486
Inventory Days69616469
Payable Days9585102118

IOL Chemicals And Pharmaceuticals Ltd Stock News

IOL Chemicals And Pharmaceuticals Ltd FAQs

The current trading price of IOL Chem & Pharma on 05-Dec-2025 16:59 is ₹84.53.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of IOL Chem & Pharma stood at ₹2,481.2.
The latest P/E ratio of IOL Chem & Pharma as of 04-Dec-2025 is 21.37.
The latest P/B ratio of IOL Chem & Pharma as of 04-Dec-2025 is 1.42.
The 52-week high of IOL Chem & Pharma is ₹126.6 and the 52-week low is ₹57.51.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of IOL Chem & Pharma is ₹2,170 ( Cr.) .

About IOL Chemicals And Pharmaceuticals Ltd

IOL Chemicals and Pharmaceuticals (IOLCP) is a leading organic chemicals manufacturers and suppliers. They are Indian manufacturer of industrial chemicals & bulk drugs for over two decades, by pursuing & implementing the highest standards of excellence in their operations, they have nurtured their capabilities by delivering consistent results and have earned the admiration of customers and stakeholders alike.

IOLCP has attained a front line position in the domestic segment and is thus contemplating to widen its horizon through global penetration. It has overseas customers from various countries like Bangladesh, Thailand, UAE, Syria, Singapore, Hong Kong, Pakistan, Egypt and many others.

IOLCP is therefore moving ahead with its vision to develop global strategic alliances with quality leaders and expand into new markets.

Product range of the company includes:

  • Acetic AcidWith a production capacity of 6.5 million metric tonnes, Acetic Acid is a significant chemical reagent & industrial chemical with a wide spectrum of applications.
  • Ethyl Acetate Ethyl Acetate is a significant industrial solvent with diverse industrial applications.
  • Acetic AnhydrideAcetic Anhydride is a well-known acid anhydride that is widely used in pharmaceutical & agrochemical industries.
  • Isobutyl BenzeneThis specialty chemical is used as an intermediate in Ibuprofen and other anti-inflammatory analgesic bulk drug
  • Mono Chloro Acetic AcidAlso know as Chloro Acetic Acid it is used in agrochemicals, pesticides, insecticides, organic chemicals etc.
  • Acetyl ChlorideAcetyl Chlorideis is colourless, near to pale yellow liquid that is used in perfume, dye, chemical, pharmaceutical bulk drugs and intermediates.
  • Ibuprofen A non-steroidal anti-inflammatory drug, Ibuprofen is used in the treatment of a variety of ailments such as arthritis, dysmenorrhoea, and is also used an analgesic.  

Clientele:

They have strong business relationships with a number of prestigious clients such as Ranbaxy Labs, CIPLA, Flex Industries, ICI Paints, Asian Paints, Pidilite, Rallis India, Hindustan Polymide, Gujarat Super Phosphate, & Avon Organics etc.

Awards & Achievements:

  • IOL Chemicals & Pharmaceuticals has consecutively been bestowed with the 2nd Prize in Chemical Sector-National Energy Conservation Award 2007, by the Ministry of Power, Government of India for the third time in a row for its efforts made towards new technology implementation to conserve the energy resources of the company.
  • IOLCP has also won Kamla Dial Gold Standard for North-West Qual Tech Standards-2006 conducted by Qimpro College Mumbai.
  • One star Export House Status Award.
  • National Energy Conservation Award 2007.
  • National Energy Conservation Award 2006.
  • National Energy Conservation Award 2005.
  • One star export House Status Award.
  • Halal Certification.
  • Kosher Certification.
  • USFDA Certification.
  • EDQM Certification.

Future Plans:

  • Chemicals Expansion - The company has planned for increasing the capacity of Acetic Acid from 50000 TPA to 66000 TPA, Ethyl Acetate from 33000 TPA to 36000 TPA & Capacity of Acetic Anhydride from 12000 TPA to 18000 TPA.
  • Pharma Expansion -  IOLCP recently boosted its Ibuprofen plant capacity to 3600 TPA from 1800 TPA and to further expand the capacity to 6000 TPA.
  • PPI's - The company has planned for installation of new manufacturing facilities of following PPIs:-Rabeprazole -Lansoprazole -Omeprazole -Pantoprazole -Esomeprazole. With annual installed capacity of 360 MT, the commercial production will start by the end of 2008.
  • Co-generation Power Plant  - To meet out its enhanced energy requirement and to become self reliance the company has also proposed for another captive co-generation plant with additional capacity of 13 MW in addition to the existing cogeneration plant of 4 MW capacity.
  • Forward Integration - The company has planned for adding two more products i.e. Mono Chloro Acetic Acid(MCA) with a capacity of 6600 TPA & Acetyl Chloride with a capacity of 4800 TPA , using Acetic Anhydride & Acetic Acid as a raw material.
  • Backward Integration - The company has planned for setting up plant for Iso-butyl Benzene(IBB) with a capacity of 6000 TPA which will be the raw material for the manufacturing of Ibuprofen.
  • Research & Development  - To develop new Molecules and process development
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×